Treatment discontinuation of long-acting injectables or oral atypical antipsychotics among Medicaid recipients with schizophrenia

MLA

Antoine C El Khoury, et al. “Treatment Discontinuation of Long-Acting Injectables or Oral Atypical Antipsychotics among Medicaid Recipients with Schizophrenia.” Journal of Medical Economics, vol. 22, May 2019, pp. 1105–12. EBSCOhost, https://doi.org/10.1080/13696998.2019.1615927.

APA

Antoine C El Khoury, Matthew Brouillette, Xue Song, David Smith, & Kruti Joshi. (2019). Treatment discontinuation of long-acting injectables or oral atypical antipsychotics among Medicaid recipients with schizophrenia. Journal of Medical Economics, 22, 1105–1112. https://doi.org/10.1080/13696998.2019.1615927

Chicago

Antoine C El Khoury, Matthew Brouillette, Xue Song, David Smith, and Kruti Joshi. 2019. “Treatment Discontinuation of Long-Acting Injectables or Oral Atypical Antipsychotics among Medicaid Recipients with Schizophrenia.” Journal of Medical Economics 22 (May): 1105–12. doi:10.1080/13696998.2019.1615927.